The variability in biological behaviour of breast carcinomas is a long standing problem. Lymph node status is still the major prognostic indicator (Fisher et al., 1983) , but also mitotic activity appears to be of considerable prognostic relevance, either as a single parameter (Schi0dt, 1966; Stenquist et al., 1981; Baak et al., 1985) , or as part of histological (Bloom & Richardson, 1957; Elston et al., 1982) or cytological (Mauriquand et al., 1986) grading. Since only a minor fraction of proliferating cells is in mitosis, the determination of the total number of proliferating cells could be a better indicator of the growth fraction of a tumour population and therefore might give more information about the biological behaviour of a tumour.
A mouse monoclonal antibody (Ki-67) has become available defining a nuclear antigen present in proliferating cells throughout the cell cycle. The antigen is absent in GO and early GI (Gerdes et al., 1983 (Gerdes et al., ,1984 The FNA smears of the benign tumours contained a low percentage of immunostained nuclei, ranging from 0.0-6.7 with a mean of 1.1 and a median of 0.4. In contrast only four of the malignant tumours showed a percentage below 2, 21 between 2 and 10 and 13 even higher than this ( Figure 2 ) with a mean of 10.5 and a median of 7.9. In comparison with the malignant primary tumours the metastases revealed even higher values with a mean of 14.3 and a median percentage of 12.3. The difference of the last two median values, assessed by the Whitney-test was statistically significant (P < 0.05).
Assessment of the Ki-67 determined proliferative tumour cell fraction in FNA smears of malignant breast lesions led to essentially similar results as recently reported in several studies (Gerdes et al., 1986; Lelle et al., 1987; McGurrin et al., 1987; Barnard et al., 1987) of Ki-67 determination on cryostat sections of breast tumours (Table II) . It appears from the data in Table II that the Ki-67 percentages of cryostat sections tend to be higher than those of the aspirates. This lower figure in aspirates may be explained by sampling differences. When the tumour is aspirated the material is derived from both peripheral and central parts of the tumour, whereas a cryostat section gives information on one part of the tumour only.
According to Baak et al. (1985) and Van der Linden et al. (1987) the mitotic activity index in histological material is the strongest independent prognostic factor in their group of patients both retrospectively and prospectively. Although the prognostic significance of the Ki-67 determined proliferative tumour cell fraction remains to be proven, we think that determination of the total cycling fraction of a tumour gives more information about prognosis than assessment of overestimation of the fraction of actually proliferating cells.
In contrast to the findings of Lelle et al. (1987) , but in agreement with the study of McGurrin et al. (1987) and Barnard et al. (1987) , we found no relation between lymph node status and percentage of Ki-67 labelled tumour cells. Neither did the 3H-thymidine labelling studies (Meyer et al., 1983; Tubiana et al., 1984) show any relation to lymph node status.
No clear-cut correlation was found in this study between tumour size and menopausal status or percentage of Ki-67 immunostained nuclei. Probably the number of investigated tumours was too low to establish such a relationship. It was interesting to see, however, that the really high values (above 40%, see Figure 3 ) were only seen in premenopausal women. In addition, the two highest values (30.5% and 19%) in the group of postmenopausal women were medullary carcinomas. It is known that the latter tumours have a high mitotic activity and display a different biological behaviour than the infiltrating duct carcinomas (Azzopardi, 1979) .
Our observation of significantly higher percentages of Ki-67 labelled tumour cells in metastases compared to primary carcinomas may point to two possibilities: tumours with a higher proliferative activity may tend to a more aggressive biological behaviour, or the higher proliferative activity of metastasized tumour cells is caused by a more favourable environment. In support of the first possibility is the prospective study of Tubiana et al. (1984) which showed that the 3H-thymidine labelling index is related to the probability of metastatic dissemination. In addition, Meyer et al. (1983) showed that the 3H-thymidine labelling index of primary breast tumours and their corresponding axillary metastases were not significantly different. Thus, it seems unlikely that the higher proliferative activity of metastasized tumours can be attributed to microenvironmental influences. Nevertheless, Further support for the hypothesis that the Ki-67 determined proliferative fraction may be of prognostic relevance can be drawn from the in vitro 3H-thymidine labelling studies of Meyer et al. (1983) and Tubiana et al. (1984) . These authors incubated small specimens of freshly obtained breast tumour tissue with 3H-thymidine and counted the number of labelled nuclei from autoradiographed microscopic sections. In the study of Meyer et al. (1983) with a follow-up period of 4 years both the lymph node status and the 3H-thymidine labelling index appeared to be the strongest independent indicators of early relapse. In the long-term prospective study of Tubiana et al. (1984) the 3H-thymidine labelling index appeared to be the most predictive independent indicator with respect to relapse-free survival and total survival. It should be noted that immunostaining is only indirect evidence of proliferation while the mitotic index and 3H-thymidine incorporation directly relate to proliferative activity. Furthermore, stains cells in GI-phase, cells arrested in this phase of the cell cycle may also be stained by Ki-67 which leads to an 
